People · Operator
Named in public records as an officer, director or promoter · active 2011–2024 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Oncolix, Inc. | — | Biotechnology | Series A | $8.8M | $9.0M | 2011 |
| Advanced Environmental Petroleum Producers Inc. | — | Biotechnology | Series A | $4.2M | $151.5M | 2017 |
| GreenJay Therapeutics, Inc. | — | Pharmaceuticals | Seed | $2.0M | $5.3M | 2024 |
Michael T Redman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael T Redman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.